Zobrazeno 1 - 10
of 368
pro vyhledávání: '"Chien Wei Su"'
Autor:
Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 3, Pp 406-420 (2024)
Background/Aims The performance of machine learning (ML) in predicting the outcomes of patients with hepatocellular carcinoma (HCC) remains uncertain. We aimed to develop risk scores using conventional methods and ML to categorize early-stage HCC pat
Externí odkaz:
https://doaj.org/article/0f7a40cce036484188ab058ab3f60d00
Autor:
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Hao-Jan Lei, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Tumor burden score (TBS) has been recently introduced to indicate the extent of tumor burden in different cancers, but its role in advanced hepatocellular carcinoma (HCC) is unclear. We aimed to determine the prognostic role of TBS in patien
Externí odkaz:
https://doaj.org/article/6d05a66185d849d9973176e908b42b2d
Autor:
Chia-Chu Fu, Cheng-Yi Wei, Chi-Jen Chu, Pei-Chang Lee, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 7, Pp 593-602 (2023)
Background: Alpha fetoprotein (AFP) is the most widely used tumor marker for hepatocellular carcinoma (HCC). Nevertheless, few studies have investigated the prognostic factors of HCC patients with normal serum AFP levels. Methods: We retrospectively
Externí odkaz:
https://doaj.org/article/edf8869eec864fc383441d4d0df6257b
Autor:
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Hung-Ting Tseng, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16987 (2023)
The severity of liver functional reserve is an important prognostic predictor in hepatocellular carcinoma (HCC). The albumin–bilirubin (ALBI), easy (EZ)-ALBI, platelet-albumin–bilirubin (PALBI), platelet–albumin (PAL) score, and MELD 3.0 score
Externí odkaz:
https://doaj.org/article/19766c2ee26648c2b6fec4b18d30ac4e
Autor:
Chun-Yang Lee, Gar-Yang Chau, Cheng-Yi Wei, Yee Chao, Yi-Hsiang Huang, Teh-Ia Huo, Ming-Chih Hou, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We investigated the outcomes of patients with ruptured hepatocellular carcinoma (HCC) and identified the optimal treatment modality for such patients. We retrospectively enrolled 91 patients with treatment-naive HCC and tumor rupture at diag
Externí odkaz:
https://doaj.org/article/e831e7417d424e70aebcc8468c272c0e
Autor:
I-Cheng Lee, Chien-Wei Su, Keng-Hsin Lan, Yuan-Jen Wang, Kuei-Chuan Lee, Han-Chieh Lin, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 9, Pp 1676-1685 (2021)
Background/Purpose: Predictors of long-term outcomes of peginterferon (PegIFN) therapy for patients with chronic hepatitis B (CHB) remain to be explored. This study aimed to evaluate the predictive value of virological and immunological biomarkers an
Externí odkaz:
https://doaj.org/article/b2b3c981e33b4a499a23b4f983c757cb
Autor:
Chi-Jung Wu, Gar-Yang Chau, I-Cheng Lee, Teh-Ia Huo, Chien-Wei Su, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 8, Pp 1563-1571 (2021)
Background/Purpose: Hepatocellular carcinoma (HCC) is a highly recurrent tumor. Antiviral therapy with nucleos(t)ide analogues (NUCs) may reduce the risk of recurrence in hepatitis B virus (HBV)-related HCC. The risk factors associated with recurrenc
Externí odkaz:
https://doaj.org/article/d76af01758394f2ab9ef288e4430713e
Autor:
Chen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, Po-Yueh Chen, Chi-Jen Chu, Keng-Hsin Lan, I-Cheng Lee, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 385-395 (2021)
Background/purpose: The treatment of chronic hepatitis C (CHC) has evolved from interferon (IFN)-based therapy to direct acting antivirals (DAAs). The effect of antiviral treatment on outcome of hepatocellular carcinoma (HCC) patients with CHC has no
Externí odkaz:
https://doaj.org/article/b971eb74441e463a96ffc6d7685c3c57
Autor:
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Publikováno v:
Cancers, Vol 15, Iss 7, p 1925 (2023)
(1) Background: The severity of liver functional reserve plays an important role in the management of hepatocellular carcinoma (HCC). Noninvasive models such as the model for end-stage liver disease (MELD), albumin-bilirubin (ALBI) grade and easy (EZ
Externí odkaz:
https://doaj.org/article/970ef139d7904b06bede613eac8c6036
Autor:
Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, Cheng-Yuan Peng, Rong-Nan Chien, Hsien-Hong Lin, Gin-Ho Lo, Wei-Wen Su, Hsing-Tao Kuo, Chao-Wei Hsu, Sien-Sing Yang, Sheng-Shun Yang, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Wan-Long Chuang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 3, Pp 956-964 (2021)
Background: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to the 8 to 14 isomers of other on-market pegylated interferon products, allowing every-two-week injection with high tolerability. It rec
Externí odkaz:
https://doaj.org/article/4401340d479a46a9a34dc86614b2c302